Altre lingue Silence Therapeutics plc OTC Markets

Azioni

SLNCF

GB00B9GTXM62

Mercato chiuso - OTC Markets Altri mercati azionari 21:57:32 10/07/2024			Variaz. 5gg	Var. 1 gen.
8,95 ^USD	+19,33%		+49,17%	+496,67%

08/07	Le azioni europee scambiate negli Stati Uniti come ricevute di deposito americane sono piatte nelle contrattazioni del lunedì	MT
02/07	I titoli azionari europei scambiati negli Stati Uniti, con le ricevute americane di deposito, sono in ribasso nel corso delle contrattazioni di martedì.	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading	08/07
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	02/07
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading	28/06
Sector Update: Health Care Stocks Decline in Afternoon Trading	27/06
European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk	27/06
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	27/06
Silence Therapeutics Says Divesiran Shows Sustained Hematocrit Reduction in Blood Cancer Study	27/06
Silence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients	27/06
Silence Therapeutics plc Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients	27/06
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	26/06
Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration	24/06
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher	21/06
Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)	20/06
Silence Therapeutics plc Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(A)	20/06
Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading	17/06
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	12/06
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	30/05
Silence Therapeutics to Present at Jefferies Global Healthcare Conference	30/05
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading	28/05
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	22/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Silence Therapeutics plc OTC Markets

Azioni

SLNCF

GB00B9GTXM62

Altre lingue

Filtri